Industry leaders will converge in Philadelphia to discuss the power of clarity in the ever-evolving life sciences sector
SOMERSET,N.J./LONDON—OCTOBER 6, 2014—Today Alliance Life Sciences announced it will be sponsoring the 2014 Revitas Industry Summit: Life Sciences, the premier event for pharmaceutical and life sciences professionals. The summit will take place in Philadelphia on October 21-22, 2014 at the Four Seasons Hotel. This two-day conference will bring together more than 250 Revitas customers, partners, industry professionals, and executives to align strategic thinking around complex issues related to contracting, revenue management, compliance, and analytics in an ever-changing marketplace.
The theme of the 2014 Revitas Industry Summit: Life Sciences, “The Power of Clarity,” will examine industry issues in managed care, institutional, and government markets, and deliver the tools, knowledge, and strategies to ensure a clear path to success. A comprehensive schedule offers attendees thought leadership discussions, best practice sessions, and user forums that explore the power of implementing an integrated enterprise solution that streamlines operations, adapts easily to changing regulations, and protects revenue.
Alliance Life Sciences’ CEO, Alan Crowther, will be presenting “Achieving Global Process Excellence”. The session will examine trends in global revenue management, business and technology innovations, and advancing analytical tools that all point to a drive for greater global operational excellence and value from revenue management operations, and a risk to those who ignore it. “Mounting pressures from payers, outsourcing, and consolidation have created a greater need for global operational excellence in the Life Sciences industry,” says Crowther. “This thought provoking presentation will cover the shift that will define tomorrow’s revenue management top performers.”
“The global life sciences landscape is in a continued state of flux, with more generic and specialty drugs flooding the market, increased pricing pressures, and changing government regulations, like the Covered Outpatient Drug Rule (AMP Final Rule)” said Jon Smith, Director, Industry Development at Revitas. “We continue to see the shift in market power moving to the payers, placing pharmaceutical manufacturers under enormous pressure to develop new strategies to remain competitive in today’s marketplace. The 2014 Revitas Industry Summit breaks down these burning questions and offers attendees a comprehensive schedule of best practice sessions, thought leadership discussions, and hands-on learning opportunities that will guide life sciencesprofessionals on a path to success.”
For more information about the 2014 Revitas Industry Summit: Life Sciences or to register for the event, please visit http://summit.revitasinc.com/.